{"created":"2023-06-19T09:50:17.835298+00:00","id":7136,"links":{},"metadata":{"_buckets":{"deposit":"7d822511-ea33-4161-913b-f7bc25798eb3"},"_deposit":{"created_by":3,"id":"7136","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"7136"},"status":"published"},"_oai":{"id":"oai:fukuyama-u.repo.nii.ac.jp:00007136","sets":["502:503:627:644"]},"author_link":["37466","37469","37463","37465","37455","37462","37468","37457","37458","37464","37460","37467","37456","37459","37461"],"item_1_biblio_info_14":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1999","bibliographicIssueDateType":"Issued"},"bibliographicPageStart":"96","bibliographicVolumeNumber":"17","bibliographic_titles":[{"bibliographic_title":"福山大学薬学部研究年報"},{"bibliographic_title":"Annual report of the Faculty of Pharmacy & Pharmaceutical Sciences, Fukuyama University","bibliographic_titleLang":"en"}]}]},"item_1_creator_6":{"attribute_name":"著者名(日)","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"世良, 庄司"}],"nameIdentifiers":[{"nameIdentifier":"37455","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"五郎丸, 毅"}],"nameIdentifiers":[{"nameIdentifier":"37456","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"鮫島, 照子"}],"nameIdentifiers":[{"nameIdentifier":"37457","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"川崎, 孝一"}],"nameIdentifiers":[{"nameIdentifier":"37458","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"小田, 利通"}],"nameIdentifiers":[{"nameIdentifier":"37459","nameIdentifierScheme":"WEKO"}]}]},"item_1_description_1":{"attribute_name":"ページ属性","attribute_value_mlt":[{"subitem_description":"P(論文)","subitem_description_type":"Other"}]},"item_1_description_11":{"attribute_name":"抄録(日)","attribute_value_mlt":[{"subitem_description":"フェンタニル(FT)とその主代謝物Nor-FTの尿中濃度を重水素標識体(FT-^2H_<19>およびNor-FT-^2H_<10>)を用いた同位体希釈分析により測定した。表面電離型イオン化検出器装備キャピラリGCによりFTは0.4-40ng/ml、Nor-FTはN-メチル誘導体化後10-400ng/mlの範囲で再現性よく測定できた。","subitem_description_type":"Other"}]},"item_1_description_12":{"attribute_name":"抄録(英)","attribute_value_mlt":[{"subitem_description":"Isotope dilution analysis was applied to determine urinary excretion of fentanyl (FT) and its main metabolite, norfentanyl (Nor-FT), by isotopic fractionation using a capillary gas chromatograph equipped with a surface ionization detector (SID). Urinary FT was determined quantitatively in the range of 0.4-40 ng/ml using deuterium labeled FT (FT-2H19) , as an internal standard. Nor-FT concentration was quantitatively determined in the range of 10-400 ng/ml using deuterium labeled Nor-FT (Nor-FT-^2H_<10>). No endogenous compounds or concomitant drugs interfered with the detection of FT and Nor-FT in the urine of patients. The present method will be useful for pharmacokinetic studies and the evaluation of drug interactions in FT metabolism.","subitem_description_type":"Other"}]},"item_1_full_name_7":{"attribute_name":"著者名よみ","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"37460","nameIdentifierScheme":"WEKO"}],"names":[{"name":"セラ, ショウジ"}]},{"nameIdentifiers":[{"nameIdentifier":"37461","nameIdentifierScheme":"WEKO"}],"names":[{"name":"ゴロウマル, ツヨシ"}]},{"nameIdentifiers":[{"nameIdentifier":"37462","nameIdentifierScheme":"WEKO"}],"names":[{"name":"サメジマ, テルコ"}]},{"nameIdentifiers":[{"nameIdentifier":"37463","nameIdentifierScheme":"WEKO"}],"names":[{"name":"カワサキ, コウイチ"}]},{"nameIdentifiers":[{"nameIdentifier":"37464","nameIdentifierScheme":"WEKO"}],"names":[{"name":"オダ, トシユキ"}]}]},"item_1_full_name_8":{"attribute_name":"著者名(英)","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"37465","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Sera, Shoji","nameLang":"en"}]},{"nameIdentifiers":[{"nameIdentifier":"37466","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Goromaru, Tsuyoshi","nameLang":"en"}]},{"nameIdentifiers":[{"nameIdentifier":"37467","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Sameshima, Teruko","nameLang":"en"}]},{"nameIdentifiers":[{"nameIdentifier":"37468","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Kawasaki, Koichi","nameLang":"en"}]},{"nameIdentifiers":[{"nameIdentifier":"37469","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Oda, Toshiyuki","nameLang":"en"}]}]},"item_1_source_id_13":{"attribute_name":"雑誌書誌ID","attribute_value_mlt":[{"subitem_source_identifier":"AN10064550","subitem_source_identifier_type":"NCID"}]},"item_1_text_10":{"attribute_name":"著者所属(英)","attribute_value_mlt":[{"subitem_text_language":"en","subitem_text_value":"FACULTY OF PHARMACY & PHARMACEUTICAL SCIENCES FUKUYAMA UNIVERSITY"},{"subitem_text_language":"en","subitem_text_value":"FACULTY OF PHARMACY & PHARMACEUTICAL SCIENCES FUKUYAMA UNIVERSITY"},{"subitem_text_language":"en","subitem_text_value":"Kagoshima University Faculty of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Kagoshima University Faculty of Medicine"},{"subitem_text_language":"en","subitem_text_value":"Kagoshima University Faculty of Medicine"}]},"item_1_text_2":{"attribute_name":"記事種別(日)","attribute_value_mlt":[{"subitem_text_value":"発表論文抄録"}]},"item_1_text_9":{"attribute_name":"著者所属(日)","attribute_value_mlt":[{"subitem_text_value":"福山大学薬学部"},{"subitem_text_value":"福山大学薬学部"},{"subitem_text_value":"鹿児島大学医学部"},{"subitem_text_value":"鹿児島大学医学部"},{"subitem_text_value":"鹿児島大学医学部"}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"1999-01-01"}],"displaytype":"detail","filename":"KJ00005784735.pdf","filesize":[{"value":"46.0 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"url":"https://fukuyama-u.repo.nii.ac.jp/record/7136/files/KJ00005784735.pdf"},"version_id":"63fa5b6e-c59c-4a24-ae78-9ab6e5e081d5"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"キャピラリガスクロマトグラフィを用いた同位体希釈分析による患者尿中フェンタニルおよび主代謝物ノルフェンタニルの定量","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"キャピラリガスクロマトグラフィを用いた同位体希釈分析による患者尿中フェンタニルおよび主代謝物ノルフェンタニルの定量"},{"subitem_title":"Isotope Dilution Analysis for Urinary Fentanyl and its Main Metabolite, Norfentanyl, in Patients by Isotopic Fractionation using Capillary Gas Chromatography","subitem_title_language":"en"}]},"item_type_id":"1","owner":"3","path":["644"],"pubdate":{"attribute_name":"公開日","attribute_value":"1999-01-01"},"publish_date":"1999-01-01","publish_status":"0","recid":"7136","relation_version_is_last":true,"title":["キャピラリガスクロマトグラフィを用いた同位体希釈分析による患者尿中フェンタニルおよび主代謝物ノルフェンタニルの定量"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2023-06-19T10:49:49.052671+00:00"}